Naoko Takebe to Leukemia
This is a "connection" page, showing publications Naoko Takebe has written about Leukemia.
Connection Strength
0.235
-
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2015 Jun; 21(6):1083-90.
Score: 0.122
-
Phase I and pharmacokinetic study of Triapine, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies. Leuk Res. 2007 Sep; 31(9):1165-73.
Score: 0.070
-
Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors. Cancer Gene Ther. 2000 Jun; 7(6):910-9.
Score: 0.044